Filing Details
- Accession Number:
- 0001110803-15-000109
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-19 20:58:00
- Reporting Period:
- 2015-03-17
- Filing Date:
- 2015-03-19
- Accepted Time:
- 2015-03-19 20:58:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1008891 | Blaine A Bowman | 5200 Illumina Way San Diego CA 92122 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-03-17 | 3,000 | $39.14 | 15,722 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-03-17 | 1,893 | $191.83 | 13,829 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-03-17 | 600 | $192.67 | 13,229 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-03-17 | 507 | $193.63 | 12,722 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2015-03-17 | 3,000 | $0.00 | 3,000 | $39.14 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 12,000 | 2009-05-07 | 2018-05-16 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 670 | Indirect | By Partnership |
| Common Stock | 198 | Indirect | By Trust |
Footnotes
- The transaction was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 1,893 shares sold ranging from $191.41 to $192.37 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 600 shares sold ranging from $192.42 to $193.20 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 507 shares sold ranging from $193.43 to $194.00 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
Billionaire Hedge Funds
